Why the study?
How do postprandial lipoprotein metabolism patterns differ among normal and hyperlipoproteinemic individuals, and what are the effects of cholestyramine and gemfibrozil?
Population
Normal subjects and individuals with type IIa, type III, and type IV hyperlipoproteinemia.
Comparison
Vitamin A-fat loading test with retinyl… vs Normal subjects and pre-treatment baseline.
Design
Cohort
Follow-up
14 hours
Authors
Loading...
Distinct postprandial patterns by hyperlipoproteinemia type respond differentially to gemfibrozil versus cholestyramine; hypothesis-generating and should not yet change practice.
How do postprandial lipoprotein metabolism patterns differ among normal and hyperlipoproteinemic individuals, and what are the effects of cholestyramine and gemfibrozil?
Postprandial lipemia has a large magnitude and long duration in both normal and hyperlipoproteinemic subjects, with distinct patterns across hyperlipoproteinemia types that are modifiable by lipid-lowering therapies.
Weintraub et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: